Your browser doesn't support javascript.
loading
Identification of the distinct genomic features in gastroesophageal junction adenocarcinoma and its Siewert subtypes.
Geng, Qirong; Lao, Jiawen; Zuo, Xiaoyu; Chen, Shangxiang; Bei, Jin-Xin; Xu, Dazhi.
Afiliación
  • Geng Q; Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, PR China.
  • Lao J; Department of Oncology, Shanghai Medical College, Fudan University, Dongan Road, Shanghai, PR China.
  • Zuo X; Department of Gastric Surgery, Sun Yat-sen University Cancer Center, Guangzhou, PR China.
  • Chen S; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, PR China.
  • Bei JX; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, PR China.
  • Xu D; Department of Gastric Surgery, Sun Yat-sen University Cancer Center, Guangzhou, PR China.
J Pathol ; 252(3): 263-273, 2020 11.
Article en En | MEDLINE | ID: mdl-32715475
ABSTRACT
Rates of gastroesophageal junction adenocarcinomas (GEJAs) have shown an alarming increase; however, the genetic background of GEJA and its Siewert classification have yet to be uncovered. Here, 60 paired tumor and normal DNA samples from GEJA patients were analyzed by whole-exome sequencing. Among them, 13 were Siewert type I, 14 were type II, and 33 were type III. A predominance of C/G>T/A substitutions was discovered in GEJA, followed by C/G>A/T substitutions. Notably, Siewert type I and type II/III display distinct sets of driver genes, mutational spectrum, and recurrently disrupted pathways. Siewert type I showed similarity to esophageal adenocarcinomas (EACs) and the chromosomal instability subtype of stomach adenocarcinomas, while Siewert type II/III showed similarity to the genomic stable subtype of stomach adenocarcinoma. We also found that mutation of FBXW7, a driver gene of GEJA, was enriched in Siewert type I. Our data identify differences between GEJA and stomach/EACs at the genomic level and provide evidence for differential treatment based on Siewert classification of GEJA. © 2020 The Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias Gástricas / Neoplasias Esofágicas / Adenocarcinoma / Biomarcadores de Tumor / Unión Esofagogástrica / Mutación Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Pathol Año: 2020 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias Gástricas / Neoplasias Esofágicas / Adenocarcinoma / Biomarcadores de Tumor / Unión Esofagogástrica / Mutación Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Pathol Año: 2020 Tipo del documento: Article